Evidence map›Paper›PMID 35497568›Full record

ArticleRSC advances2021

Poly[2-(dimethylamino)ethyl methacrylate-

Petr Šálek, Jiří Trousil, Jitka Nováčková, Jiřina Hromádková, Andrii Mahun, Libor Kobera

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Membrane-Focused Strategies AgainstAntibiotics (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Cellulose-Gels (Basel, Switzerland) · 2022
    Article
  5. Recent Advances in Antimicrobial Nano-Drug Delivery Systems.Nanomaterials (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Petr ŠálekInstitute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic Heyrovského nám. 2 162 06 Prague 6 Czech Republic salek@imc.cas.cz.ORCID https://orcid.org/0000-0002-5021-9794
Jiří TrousilInstitute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic Heyrovského nám. 2 162 06 Prague 6 Czech Republic salek@imc.cas.cz.
Jitka NováčkováInstitute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic Heyrovského nám. 2 162 06 Prague 6 Czech Republic salek@imc.cas.cz.
Jiřina HromádkováInstitute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic Heyrovského nám. 2 162 06 Prague 6 Czech Republic salek@imc.cas.cz.
Andrii MahunInstitute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic Heyrovského nám. 2 162 06 Prague 6 Czech Republic salek@imc.cas.cz.
Libor KoberaInstitute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic Heyrovského nám. 2 162 06 Prague 6 Czech Republic salek@imc.cas.cz.ORCID https://orcid.org/0000-0002-8826-948X
Czech Academy of Sciences, Institute of Macromolecular Chemistry · CZCharles University · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial infections and antimicrobial resistance are one of the major public health problems and various strategies to prevent potential threats have been developed. Protonated polymers were proven as efficient agents against several microbial pathogens. Poly[2-(dimethylamino)ethyl methacrylate] (PDMAEMA) linear polymer and its copolymers represent one example of functional materials which inhibit the growth of both harmful Gram-negative and Gram-positive bacteria. However, the antimicrobial effect of positively charged PDMAEMA particles has been never tested. In this report, we deeply studied several parameters of free-radical polymerization, including the effect of crosslinking monomer, medium composition, solvency and polarity, and type and concentration of initiator and stabilizer, to fabricate high-quality poly[2-(dimethylamino)ethyl methacrylate-

Identifiers

PMID35497568
PMCPMC9042309
OpenAlexW3206814236

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.